Annalisa Piccinno - Publications

Evaluating the Impact of Hepatic or Renal Impairment on Tanimilast (CHF6001) Pharmacokinetics: Two Open-Label, Parallel-Group, Single-Center Studies.

Journal: Clinical and translational science

Published: February 20, 2025

A Randomized, Controlled Trial to Investigate the Efficacy of Nebulized Poractant Alfa in Premature Babies with Respiratory Distress Syndrome.

Journal: The Journal of pediatrics

Published: October 05, 2021

A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: December 21, 2020

Reply.

Journal: The Journal of pediatrics

Published: August 11, 2020

Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial.

Journal: The Journal of pediatrics

Published: March 18, 2020

Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler.

Journal: British journal of clinical pharmacology

Published: June 11, 2018

A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome.

Journal: Archives of disease in childhood. Fetal and neonatal edition

Published: January 16, 2017

Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study.

Journal: Pulmonary pharmacology & therapeutics

Published: November 04, 2016

Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.

Journal: Pulmonary pharmacology & therapeutics

Published: June 27, 2014

A clinical pharmacology study of fixed vs. free combination of inhaled beclometasone dipropionate and formoterol fumarate dry powder inhalers in asthmatic adolescents.

Journal: British journal of clinical pharmacology

Published: March 07, 2014

Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent.

Journal: Respiratory medicine

Published: January 30, 2014

The systemic exposure to inhaled beclometasone/formoterol pMDI with valved holding chamber is independent of age and body size.

Journal: Pulmonary pharmacology & therapeutics

Published: January 28, 2014